Tophistorier inden for pharma/biotek: https://firstwordpharma.com/river/top-stories?nle=6593&nlc=30

]]>https://dev.proinvestor.com/forum/topic/400884/pharma-marts-2024RSS for NodeSun, 07 Jun 2026 07:07:23 GMTMon, 04 Mar 2024 04:15:44 GMT60Gilead grabs rights to Xilio’s tumour-activated IL-12 programme
The early-stage candidate XTX301 may have the potential to treat a broad range of cancers, both as monotherapy and as part of combo regimens. https://firstwordpharma.com/story/5841367?from=article

]]>https://dev.proinvestor.com/forum/post/8038035https://dev.proinvestor.com/forum/post/8038035Fri, 29 Mar 2024 04:57:34 GMTMerck & Co.'s Keytruda wins EU nod for sixth lung cancer use
Decision marks the first approval in Europe for an anti-PD-1/L1 therapy in resectable non-small-cell lung cancer. https://firstwordpharma.com/story/5841409?from=article

]]>https://dev.proinvestor.com/forum/post/8038038https://dev.proinvestor.com/forum/post/8038038Fri, 29 Mar 2024 04:56:54 GMTFDA pumps brakes on Applied's govorestat, seeks more time for review https://firstwordpharma.com/story/5841711?from=article

]]>https://dev.proinvestor.com/forum/post/8038037https://dev.proinvestor.com/forum/post/8038037Fri, 29 Mar 2024 04:53:08 GMTBMS’s Zeposia misses in Phase III Crohn’s disease study https://firstwordpharma.com/story/5841713?from=article

]]>https://dev.proinvestor.com/forum/post/8038036https://dev.proinvestor.com/forum/post/8038036Fri, 29 Mar 2024 04:52:27 GMTInvesteringspodcasten: Hør om opturen i Teva, nedtur for Mærsk og børsnotering af Reddit. Værterne kommer også rundt om insidersalg i Amazon, Meta og Palantir. Hør også om ECD sætter renten ned før FED. https://www.proinvestor.com/boards/119541

]]>https://dev.proinvestor.com/forum/post/8038033https://dev.proinvestor.com/forum/post/8038033Wed, 27 Mar 2024 14:09:14 GMTLundbeck får godkendt langtidsvirkende middel til behandling af skizofreni i EU https://www.proinvestor.com/investornyt/1137101/lundbeck-far-godkendt-langtidsvirkende-middel-til-behandling-af-skizofreni-i-eu

]]>https://dev.proinvestor.com/forum/post/8038034https://dev.proinvestor.com/forum/post/8038034Wed, 27 Mar 2024 06:52:34 GMTFDA Approves Merck's Winrevair For Treatment Of Pulmonary Arterial Hypertension In Adults https://www.proinvestor.com/investornyt/1137074/fda-approves-mercks-winrevair-for-treatment-of-pulmonary-arterial-hypertension-in-adults

]]>https://dev.proinvestor.com/forum/post/8038030https://dev.proinvestor.com/forum/post/8038030Wed, 27 Mar 2024 03:42:39 GMTUltimovacs - Jeg var investor i Ultimovacs før INITIUM studiet kom ud med resultater. Jeg valgte ikke at sælge mine aktier fordi jeg syntes studie-resultatet ikke entydigt viser at vaccinen UV1 ikke virker. Jeg mener der har været en overreaktion. Jeg har derfor haft meget travlt med at tale med fagfolk om dette. Jeg har besluttet at invester yderligere de seneste dage. Jeg skal opdatere med et debat-indlæg senere i påske-ugen.

]]>https://dev.proinvestor.com/forum/post/8038029https://dev.proinvestor.com/forum/post/8038029Mon, 25 Mar 2024 07:21:30 GMTAstraZeneca Announces FDA Approval For Ultomiris - Quick Facts https://www.proinvestor.com/investornyt/1135990/astrazeneca-announces-fda-approval-for-ultomiris-quick-facts

]]>https://dev.proinvestor.com/forum/post/8038032https://dev.proinvestor.com/forum/post/8038032Mon, 25 Mar 2024 07:11:23 GMTTak for indsatsen i Bava chatten, The Note! Desværre er en lille hård klike gået helt i selvsving derinde i kritik af alt og alle der har med Bava at gøre. Så meget at ingen andre gider skrive derinde, så længe de folder sig ud. Vi snax ved derinde senere på året/næste år, efterhånden som øget omsætning/indtjening sætter sig igennem

]]>https://dev.proinvestor.com/forum/post/8038026https://dev.proinvestor.com/forum/post/8038026Thu, 21 Mar 2024 09:35:38 GMTSydbank ser pænt potentiale i Lundbecks to varmeste interne lægemiddelkandidater https://www.proinvestor.com/investornyt/1133092/sydbank-ser-paent-potentiale-i-lundbecks-to-varmeste-interne-laegemiddelkandidater

]]>https://dev.proinvestor.com/forum/post/8038025https://dev.proinvestor.com/forum/post/8038025Mon, 18 Mar 2024 06:28:07 GMTJohnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It. https://www.proinvestor.com/investornyt/1132739/johnson-amp-johnson-stock-is-great-heres-why-you-shouldnt-buy-it

]]>https://dev.proinvestor.com/forum/post/8038027https://dev.proinvestor.com/forum/post/8038027Sat, 16 Mar 2024 07:33:14 GMTLundbeck går videre med studie af migrænemiddel https://www.proinvestor.com/investornyt/1132204/lundbeck-gar-videre-med-studie-af-migraenemiddel

]]>https://dev.proinvestor.com/forum/post/8038023https://dev.proinvestor.com/forum/post/8038023Fri, 15 Mar 2024 07:52:29 GMTPharma Stock Roundup: NVO's New Obesity Pill Data, RHHBY, AZN's Pipeline Updates https://www.proinvestor.com/investornyt/1129459/pharma-stock-roundup-nvos-new-obesity-pill-data-rhhby-azns-pipeline-updates

]]>https://dev.proinvestor.com/forum/post/8038031https://dev.proinvestor.com/forum/post/8038031Sat, 09 Mar 2024 08:11:43 GMTWhy Eli Lilly Stock Flopped on Friday https://www.proinvestor.com/investornyt/1129450/why-eli-lilly-stock-flopped-on-friday

]]>https://dev.proinvestor.com/forum/post/8038022https://dev.proinvestor.com/forum/post/8038022Sat, 09 Mar 2024 07:15:27 GMTEli Lillys alzheimerskandidat står over for yderligere
forsinkelsehttps://www.proinvestor.com/investornyt/1129011/eli-lillys-alzheimerskandidat-star-over-for-yderligere-forsinkelse

]]>https://dev.proinvestor.com/forum/post/8038021https://dev.proinvestor.com/forum/post/8038021Fri, 08 Mar 2024 11:44:17 GMTGodmorgen

]]>https://dev.proinvestor.com/forum/post/8038039https://dev.proinvestor.com/forum/post/8038039Fri, 08 Mar 2024 05:07:56 GMTGodmorgen

]]>https://dev.proinvestor.com/forum/post/8038028https://dev.proinvestor.com/forum/post/8038028Thu, 07 Mar 2024 05:26:21 GMTgod morgen

]]>https://dev.proinvestor.com/forum/post/8038018https://dev.proinvestor.com/forum/post/8038018Wed, 06 Mar 2024 05:17:59 GMTAlk - er der ikke et gap i 114 der skal lukkes? (jeg skal ha' købt dem tilbage jeg solgte )

]]>https://dev.proinvestor.com/forum/post/8038014https://dev.proinvestor.com/forum/post/8038014Tue, 05 Mar 2024 13:57:39 GMTLundbeck gør klar til fase 3-studie af MSA-middel efter opmuntrende data https://www.proinvestor.com/investornyt/1127205/lundbeck-gor-klar-til-fase-3-studie-af-msa-middel-efter-opmuntrende-data

]]>https://dev.proinvestor.com/forum/post/8038020https://dev.proinvestor.com/forum/post/8038020Tue, 05 Mar 2024 10:24:44 GMTGodmorgen

]]>https://dev.proinvestor.com/forum/post/8038024https://dev.proinvestor.com/forum/post/8038024Tue, 05 Mar 2024 05:32:27 GMTAstraZeneca's Datopotamab Deruxtecan Applications Validated In EU For Lung Cancer, Breast Cancer https://www.proinvestor.com/investornyt/1126526/astrazenecas-datopotamab-deruxtecan-applications-validated-in-eu-for-lung-cancer-breast-cancer

]]>https://dev.proinvestor.com/forum/post/8038017https://dev.proinvestor.com/forum/post/8038017Mon, 04 Mar 2024 07:39:34 GMTNovartis: New SMART Study Data Continues To Support Zolgensma's Clinical Benefits In SMA https://www.proinvestor.com/investornyt/1126513/novartis-new-smart-study-data-continues-to-support-zolgensmas-clinical-benefits-in-sma

]]>https://dev.proinvestor.com/forum/post/8038019https://dev.proinvestor.com/forum/post/8038019Mon, 04 Mar 2024 06:05:36 GMT